Prospective Assessment of No Evidence of Disease Activity-4 Status in Early Disease Stages of Multiple Sclerosis in Routine Clinical Practice

Frontiers in Neurology - Switzerland
doi 10.3389/fneur.2019.00788
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Frontiers Media SA

Related search

Assessing ‘No Evidence of Disease Activity’ Status in Patients With Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study

CNS Drugs
PsychiatryMental HealthNeurologyPharmacology
2017English

No Association of Tobacco Use and Disease Activity in Multiple Sclerosis: Table.

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2016English

Assessment of Early Evidence of Multiple Sclerosis in a Prospective Study of Asymptomatic High-Risk Family Members

JAMA Neurology
Neurology
2017English

Patterns of Disease Activity in Multiple Sclerosis: Clinical and Magnetic Resonance Imaging Study.

BMJ
1990English

No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing–Remitting Multiple Sclerosis

Advances in Therapy
MedicinePharmacology
2014English

Correction To: Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis

CNS Drugs
PsychiatryMental HealthNeurologyPharmacology
2018English

Epstein-Barr Virus and Disease Activity in Multiple Sclerosis

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2005English

“No Evident Disease Activity”: The Use of Combined Assessments in the Management of Patients With Multiple Sclerosis

Multiple Sclerosis
Neurology
2017English

Cerebrovascular Reactivity and Disease Activity in Relapsing-Remitting Multiple Sclerosis

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy